AUTLVSCLYM• 3 Months (Normalized)
AUTL vs CLYM (Autolus Therapeutics plc vs Climb Bio Inc.)
Showing Closing Date Range from Jun, 19 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AUTL Performance $1.92
+28.86%
Autolus Therapeutics plc
Normalized Baseline0.00%
CLYM Performance $14.06
+15.44%
Climb Bio Inc.
Normalized Baseline0.00%
Alpha Spread Margin AUTL LEADS
+13.42%
AUTL outperforming by 13.42%
AUTLCLYM
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AUTL CLYM
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | AUTL Price | AUTL Gain (%) | CLYM Price | CLYM Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $1.92 | +28.86% | $14.06 | +15.44% | +13.42% |
| Sep 16, 2026 | $1.87 | +25.50% | $14.11 | +15.85% | +9.65% |
| Sep 15, 2026 | $1.89 | +26.85% | $13.91 | +14.20% | +12.65% |
| Sep 14, 2026 | $1.94 | +30.20% | $14.56 | +19.54% | +10.66% |
| Sep 11, 2026 | $1.88 | +26.17% | $14.25 | +17.00% | +9.17% |
| Sep 10, 2026 | $1.96 | +31.54% | $14.95 | +22.74% | +8.80% |
| Sep 09, 2026 | $2.03 | +36.24% | $15.05 | +23.56% | +12.68% |
| Sep 08, 2026 | $2.11 | +41.61% | $15.90 | +30.54% | +11.07% |
| Sep 04, 2026 | $2.24 | +50.34% | $15.52 | +27.42% | +22.92% |
| Sep 03, 2026 | $2.29 | +53.69% | $14.59 | +19.79% | +33.90% |
| Sep 02, 2026 | $2.24 | +50.34% | $15.05 | +23.56% | +26.78% |
| Sep 01, 2026 | $2.31 | +55.03% | $14.82 | +21.67% | +33.36% |
| Aug 31, 2026 | $2.35 | +57.72% | $13.73 | +12.73% | +44.99% |
| Aug 28, 2026 | $2.34 | +57.05% | $14.57 | +19.62% | +37.43% |
| Aug 27, 2026 | $2.36 | +58.39% | $15.06 | +23.65% | +34.74% |
Page 1 of 5